Live Breaking News & Updates on Silverstein Foundation For Parkinson|Page 4

Stay updated with breaking news from Silverstein foundation for parkinson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Gain Therapeutics, Inc.: Gain Therapeutics Announces Third Quarter 2023 Financial Results and Business Update

Gain Therapeutics, Inc.: Gain Therapeutics Announces Third Quarter 2023 Financial Results and Business Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Susan Sharpe , Matthias Alder , Gain Therapeutics Inc , Institute For Research , International Congress , Exchange Commission , Silverstein Foundation For Parkinson , Company Annual Report On Form , Michaelj Fox Foundation For Parkinson Research , Bellberry Human Research Ethics Committee , Movement Disorders , Exchange Commission On , Linnden Communications , Chief Executive Officer , Nature Scientific Reports , Southern Switzerland , Months Ended September , Silverstein Foundation , Gain Therapeutics , Private Securities Litigation Reform Act , Annual Report , Media Contact , Ihre Watchlist ,

Gain Therapeutics Announces Dosing of First Two Subjects in Phase 1 Clinical Trial of GT-02287, a Novel GCase-targeting Small Molecule Therapy for GBA1 Parkinson's Disease

First small molecule allosteric binder discovered with Gain’s computational drug discovery platform enters clinical developmentBETHESDA, Md., Oct. 04, 2023 Gain Therapeutics, Inc. , a. ....

Matthias Alder , Susan Sharpe , Exchange Commission , Silverstein Foundation For Parkinson , Company Annual Report On Form , National Gaucher Foundation , Michaelj Fox Foundation For Parkinson Research , Treatment Initiative , Linnden Communications , Exchange Commission On , Gain Therapeutics Inc , Chief Executive Officer , Robin Ely , Regenerative Medicine , Clinical Scientific Consultant , Silverstein Foundation , Gain Therapeutics , Private Securities Litigation Reform Act , Annual Report , Media Contact ,

Gain Therapeutics to Present at the Cambridge Healthtech Institute's 2nd Annual Neurodegeneration Targets Conference

Gain Therapeutics to Present at the Cambridge Healthtech Institute's 2nd Annual Neurodegeneration Targets Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Matthias Alder , Susan Sharpe , Company Annual Report On Form , Cambridge Healthtech Institute , Gain Therapeutics Inc , Exchange Commission On , Exchange Commission , Linnden Communications , Michaelj Fox Foundation For Parkinson Research , Silverstein Foundation For Parkinson , Chief Executive Officer , Gain Therapeutics , Annual Neurodegeneration Targets Conference , Drug Discovery , Progressive Central Nervous System , Sheraton Boston , Targeting Glucocerobrosidase , Allosteric Activators , Silverstein Foundation , Private Securities Litigation Reform Act , Annual Report , Media Contact ,

Gain Therapeutics (GANX) Receives Approval to Commence Phase 1 Clinical Study of GT-02287 from the Human Research Ethics Committee (HREC) in Australia

Gain Therapeutics (GANX) Receives Approval to Commence Phase 1 Clinical Study of GT-02287 from the Human Research Ethics Committee (HREC) in Australia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Matthias Alder , Bellberry Human Research Ethics Committee , Silverstein Foundation For Parkinson , Michaelj Fox Foundation For Parkinson Research , Gain Therapeutics Inc , Movement Disorders , International Congress , Gain Therapeutics , Chief Executive Officer , Silverstein Foundation ,

Gain Therapeutics Receives Approval to Commence Phase 1 Clinical Study of GT-02287 from the Human Research Ethics Committee (HREC) in Australia

First drug candidate identified with Gain’s proprietary computational drug discovery platform SEE-Tx® to enter clinical development phase BETHESDA, Md., Sept. 12, 2023 . ....

Matthias Alder , Susan Sharpe , International Congress , Movement Disorders , Company Annual Report On Form , Linnden Communications , Silverstein Foundation For Parkinson , Gain Therapeutics Inc , Exchange Commission On , Michaelj Fox Foundation For Parkinson Research , Bellberry Human Research Ethics Committee , Exchange Commission , Chief Executive Officer , Silverstein Foundation , Gain Therapeutics , Private Securities Litigation Reform Act , Annual Report , Media Contact ,